Adar1 Capital Management, LLC

CIK 0001940272

10% Owner

Filings

Latest May 21, 2026

Issuers covered

Showing

10 of 10

Page 1

Track record

14 of 28 open-market trades scored (50% price coverage) - 14 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).

Horizon	Trades	Win rate	Avg	Median	Best	Worst
30 days	14	79%	+12.8%	+13.8%	+32.1%	-19.1%
90 days	11	73%	+7.2%	+8.7%	+34.7%	-34.6%
180 days	11	73%	+29.1%	+23.1%	+51.2%	-2.6%
365 days	8	100%	+77.9%	+20.9%	+175.1%	+20.9%

Issuers

Companies where Adar1 Capital Management, LLC has filed

Ticker	Issuer	Filings	Last filed
KROS	Keros Therapeutics, Inc.	4	Oct 15, 2025
RLYB	Rallybio Corp	4	May 20, 2026
INM	Inmed Pharmaceuticals Inc.	1	May 21, 2026
PIRS	Pieris Pharmaceuticals, Inc.	1	Aug 12, 2024

All filings

10 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
May 21, 2026	INMInmed Pharmaceuticals Inc.	PPurchase	200,000	$1.5604	$312,080
May 20, 2026	RLYBRallybio Corp	PPurchase	10,000	$13.9822	$139,822
May 15, 2026	RLYBRallybio Corp	PPurchase	75,178	$14.00	$1,052,492
May 13, 2026	RLYBRallybio Corp	PPurchase	25,000	$14.00	$350,000
May 6, 2026	RLYBRallybio Corp	PPurchase	116,904	$13.9705	$1,633,207
Oct 15, 2025	KROSKeros Therapeutics, Inc.	SSale	4,391,237	$17.75	$77,944,457
Jun 24, 2025	KROSKeros Therapeutics, Inc.	XITM Exercise	1,400	$70.00	$98,000
Jun 12, 2025	KROSKeros Therapeutics, Inc.	Holdings only	-	-	-
Apr 11, 2025	KROSKeros Therapeutics, Inc.	PPurchase	500,000	$10.33	$5,165,000
Aug 12, 2024	PIRSPieris Pharmaceuticals, Inc.	PPurchase	3,000	$14.8929	$44,679

Showing 1-10 of 10

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value